Disposable Diabetes Lancets Companies and Competitive Landscape
The disposable diabetes lancets market size was estimated at US$ 1.19 billion in 2023 and is projected to grow to US$ 1.9 billion by 2034, rising at a compound annual growth rate (CAGR) of 4.33% from 2024 to 2034.
Top Companies in the Disposable Diabetes Lancets:
- A. Menarini Diagnostics
- Acon Diabetes Care
- AdvaCare Pharma
- Arkray Healthcare Pvt. Ltd.
- BioCare Corporation
- CVS Pharmacy
- Drawbridge Health
- Genteel
- Hoffman La-Roche Ltd.
- Owen Mumford
- Pip Diabetes
- SD Biosensor Healthcare Pvt. Ltd.
Recent Developments in the Disposable Diabetes Lancets Market
- In April 2024, Drawbridge Health announced that they received 510(k) clearance from the US FDA for its advanced at-home blood sampling device, NanoDrop Lancet, for OTC use. NanoDrop Lancet is the US FDA-approved OTC blood-lancing device labeled for the upper arm.
- In March 2023, Pip Diabetes developed painless, single-use lancets to help customers get a clean and painless blood sample. The lancets are precision-engineered to ensure proper needle gauge and depth and to minimize vibration, eliminating pain from the fingerstick.
If you have any questions, please feel free to contact us at
